Online Acceptance-based Behavioural Treatment for Fibromyalgia
Online Acceptance-Based Behavioural Treatment for Fibromyalgia
1 other identifier
interventional
67
1 country
1
Brief Summary
A recent study published by the Canadian Pain Society estimated the direct health care costs of chronic pain to be about 6 billion dollars. Over 1/3 of all Canadians reported that they either missed work or experienced reduced productivity due to chronic pain. Fibromyalgia Syndrome (FMS)is a condition that affects up to 10% of the Canadian population, many of whom are still in the prime of their lives. While pain and fatigue are prominent symptoms, FMS sufferers often experience sleep disturbance, gastrointestinal upset, chronic headache, memory and thinking problems, and depression. Standard treatments focus on medication and physical exercise but are not always successful. Acceptance-Based behavioural therapy (ABBT) is a relatively new approach that has been effective not only in treating mental health concerns such as anxiety and depression, but also other medical conditions such as diabetes and chronic pain. A novel ABBT for FMS was developed and pilot tested with a small group of participants. The results of this preliminary study were promising. Unfortunately, many people cannot adequately access available treatment due to long wait lists, prohibitive costs, or time/location constraints. Online treatments may offer improved access to care without reducing the effectiveness of treatment. Therefore, the ABBT for FMS used in the pilot study is being adapted to an online format and will be evaluated with a larger group of participants. A wait-list/control group will be employed to evaluate the effectiveness of the online treatment as compared with treatment-as-usual. If found effective, this treatment would offer patients easier access to care at a significantly reduced cost to the health care system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 2012
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2012
CompletedFirst Posted
Study publicly available on registry
July 17, 2012
CompletedStudy Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedDecember 2, 2015
November 1, 2015
1.9 years
June 25, 2012
November 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in Fibromyalgia Impact Questionnaire-revised
Assesses overall impact of Fibromyalgia symptoms on daily functioning
baseline, 2 months, 5 months
Secondary Outcomes (9)
Change from baseline in Center for Epidemiological Studies Depression Scale
Baseline, 2 months, 5 months
Change from baseline in Chronic Pain Acceptance Questionnaire
Baseline, 2 months, 5 months
Change from baseline in Cognitive Fusion Questionnaire
Baseline, 2 months, 5 months
Change from baseline in McGill Pain Questionnaire- short form
Baseline, 2 months, 5 months
Change from baseline in Five Facet Mindfulness Questionnaire
Baseline, 2 months, 5 months
- +4 more secondary outcomes
Study Arms (2)
Treatment-as-usual
ACTIVE COMPARATORParticipants continue their pre-study treatment plan, based on their physician/other professional recommendations
Online ABBT treatment + TAU
EXPERIMENTALParticipants to complete a 6-unit online Acceptance-based behavioural treatment including training in pacing, mindfulness, acceptance, cognitive defusion, willingness, and exercise while also maintaining their pre-study treatment.
Interventions
Behavioral intervention focusing on acceptance, mindfulness and values-based living instead of focus on symptom control
Participants will continue pre-study treatment under their current licensed practitioners. Intervention may include drug treatment, physical therapy, or other
Eligibility Criteria
You may qualify if:
- Participants of either sex aged 18 years and older with a formal diagnosis of FMS will be recruited.
- Individuals younger than 18 years of age will be excluded in order to ensure all participants have reached the age of majority and can provide consent.
- They will have a pain intensity rating of at least 4/10 based on self-report. Participants will also be screened using the Wolfe et al (2010) criteria during the in-person session to ensure they meet criteria for FMS.
- Must reside in and complete study from within Manitoba, Canada
You may not qualify if:
- People with co-morbidities such as rheumatologic conditions, other conditions affecting the immune system (e.g. chronic fatigue syndrome, multiple sclerosis, lupus), brain injury, cognitive impairment that would limit a participant's ability to complete informed consent, active psychosis, substance abuse, uncontrolled major depression or bipolar disorder, active suicidality, or those who have current active injury claims will be excluded.
- Given the use of a large amount of reading materials, participants will be asked if they have completed at least grade 9 in high school. Those who have only completed grade 8 or lower will be excluded.
- Further, participants will be asked to maintain their pre-study treatment regime and not making changes to their medications or beginning other treatments for the duration of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Sciences Centre
Winnipeg, Manitoba, R3A 1R9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heather Simister, MA
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Candidate
Study Record Dates
First Submitted
June 25, 2012
First Posted
July 17, 2012
Study Start
September 1, 2012
Primary Completion
August 1, 2014
Study Completion
August 1, 2015
Last Updated
December 2, 2015
Record last verified: 2015-11